Initiator Pharma A/S: Financial statements 2017
CVR: 37663808
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Initiator Pharma A/S (CVR 37663808) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -8,180,000 and a net result of DKK -8,582,000. Equity in the 2017 report amounted to DKK 5,964,000. The solvency ratio was 64.1%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -8,180,000
- Profit/Loss
- DKK -8,582,000
- Equity
- DKK 5,964,000
- Total Assets
- DKK 9,298,000
- Employees
- 2
Official annual report
Keep an eye on Initiator Pharma A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Initiator Pharma A/S has published its interim report for the period May 2, 2016 to December 31, 2016.
As of January 20, 2017, Claus Elsborg Olesen has joined the board of directors of Initiator Pharma A/S.
About Initiator Pharma A/S
Initiator Pharma A/S is a Danish company of the type Aktieselskab based in København N, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Elsborg Olesen. The board consists of Gunnar Magnus Severus Modée Persson (chair), Annette Ingegerd Marie Colin, Claus Elsborg Olesen and Majken Christina Östberg Lloyd. The company is owned by Linc AB and Adrigo Asset Management. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK -14,828,000 and a net result of DKK -13,687,000 compared with DKK -12,932,000 the year before. Equity in the 2025 report amounted to DKK 29,546,000.